Leonard John Minsider trades

In SEC Form 4 filings, Leonard John M is listed as President and CEO of Intellia Therapeutics, Inc. (NTLA). In the last 90 days, Leonard John M sold $286.8K of Intellia Therapeutics, Inc. (NTLA) on the open market and bought none. All 2 sales were reported under a 10b5-1 trading plan.

Companies and roles

Company	Role	Transactions	Last filed
NTLAIntellia Therapeutics, Inc.	President and CEO	2	Aug 24

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-08-24

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
NTLAIntellia Therapeutics, Inc.	Aug 21	Aug 24	S	2,785	$13.00	Sale −$36,205	1,147,064	Yes	Form 4
NTLAIntellia Therapeutics, Inc.	Aug 20	Aug 24	S	19,890	$12.60	Sale −$250,614	1,149,849	Yes	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.